TSPAN8 inhibitors are chemical compounds that target the Tetraspanin-8 (TSPAN8) protein, which belongs to the larger tetraspanin family of membrane proteins. Tetraspanins are integral to cellular membranes and are involved in the organization of multi-protein complexes, often referred to as tetraspanin-enriched microdomains (TEMs). TSPAN8 is particularly known for its role in facilitating cell adhesion, migration, and the regulation of cell-to-cell communication. It interacts with a variety of other membrane proteins, including integrins and signaling receptors, to influence cellular dynamics. TSPAN8 is involved in processes such as cellular proliferation, differentiation, and matrix remodeling. Inhibitors of TSPAN8 work by interfering with its ability to form complexes with other proteins, thereby altering the behavior and organization of the cellular membrane.
The molecular mechanisms by which TSPAN8 inhibitors exert their effects are thought to involve the disruption of key protein-protein interactions within the tetraspanin web. These inhibitors may target specific domains of TSPAN8, such as the extracellular loops, which are responsible for its interactions with partner proteins. By blocking these interactions, TSPAN8 inhibitors can affect cellular signaling pathways that rely on the integrity of TEMs. Furthermore, TSPAN8 inhibitors can influence membrane fluidity and protein trafficking, as tetraspanins are involved in regulating the spatial organization of membrane proteins. As a result, these inhibitors are often used in research settings to study the role of TSPAN8 in processes like cell motility, invasion, and structural organization. The modulation of TSPAN8 activity through inhibition provides valuable insights into the molecular architecture of cellular membranes and the complex networks of protein interactions that control cell behavior.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
Src family kinase inhibitor that may affect TSPAN8-mediated signaling pathways which are dependent on Src kinase activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor that may disrupt TSPAN8-associated signal transduction, affecting cell proliferation and survival. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
MEK inhibitor which could potentially alter TSPAN8-related signaling, influencing cell migration and interaction. | ||||||
GW4869 | 6823-69-4 | sc-218578 sc-218578A | 5 mg 25 mg | $203.00 $611.00 | 24 | |
Neutral sphingomyelinase inhibitor that may impair exosome release, a process that TSPAN8 is known to influence. | ||||||
NSC 23766 | 733767-34-5 | sc-204823 sc-204823A | 10 mg 50 mg | $151.00 $609.00 | 75 | |
Rac1 inhibitor that might interfere with TSPAN8's role in actin cytoskeleton organization and cell motility. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
ROCK inhibitor which can influence cell morphology and motility, processes that could be associated with TSPAN8 activity. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
Intracellular calcium chelator, potentially modulating calcium-dependent processes involving TSPAN8. | ||||||
Manumycin A | 52665-74-4 | sc-200857 sc-200857A | 1 mg 5 mg | $219.00 $634.00 | 5 | |
Farnesyltransferase inhibitor, may affect TSPAN8’s role in the regulation of cell growth. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor, could influence apoptosis and other cellular responses where TSPAN8 is implicated. | ||||||